AKCEA THERAPEUTICS (AKCA) analyst actions
Rating and price-target actions on AKCA in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the AKCA overview →
No AKCA analyst action events in the measured window.
Nothing matched in the current window — the AKCA overview has every event we measure for this name.
Get an email when AKCA moves on news →Keep exploring
More AKCA: earnings → · SEC filings → · AKCA overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Vericel Corporation (VCEL) | 406 | -0.19% | 40% |
| SPRING BANK PHARMACEUTICALS (SBPH) | 404 | 0.00% | 37% |
| Blueprint Medicines Corporation (BPMC) | 401 | -0.03% | 46% |
| EDGE THERAPEUTICS (EDGE) | 401 | -0.05% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.